LAVAL, QC, April 16, 2014 /CNW Telbec/ - Ergoresearch Ltd (TSXV: ERG) announced today the successful completion of new scanner technology destined for the orthopedic industry. More accurate than traditional cast-making methods that rely on plaster bandaging, this technology means orthotists will no longer resort to plaster when applying casts.
This newly developed technology is easy to use and very safe. Now any body part can be scanned in both 3D and in real time. Scanned files are transferred by Internet to Ergoresearch's computing platforms, where the data is used to manufacture custom fit medical orthotics.
While the Company's Web-Fit custom foot orthotics' computer-assisted design and manufacturing system relies on a pressure distribution system, creating a knee brace requires '3D contoured imaging.' In this context, a scanner is very advantageous and advances are significant.
The new device was recently implemented and many clinicians are already using it to cast knees.
Danielle Boucher, of one the first clinicians to use the scanner technology who also took part in the research project states: "This technology is faster than traditional plaster casts - it cuts over 50% in clinical time. For the patient, not having a cast covering their leg also presents distinct advantages. Finally, by scanning the patient's knee and sending the file via Internet, we increase precision and eliminate time and costs associated with shipping the molds to the manufacturing plant."
ECOLOGICAL GREENER METHODS
Ergoresearch's group of subsidiaries alone account for eliminating hundreds of overland shipments. In addition, with the thousands of pounds of plaster used annually, clearly environmental benefits are important.
If practical, ecological and clinical benefits are obvious, financial benefits are major. Scanners generate substantial savings:
- Plaster costs
- Shipping costs
- Increased productivity
"High precision scanners that have been on the market for a number of years cost $20,000 on average. Their high price tag remains an obstacle to their broader adoption by the orthopedic industry. Our new scanning device and its software developed in this R&D project are available at a much lower price than that of a high precision scanner
"Given the orthopedic industry's needs are far less complex than those of the aerospace and automotive industries, Ergoresearch was able to develop a scanning system that meets industry standards rigorously, but at a fraction of the cost of existing technologies," explains Mr. Louis Desrosiers, VP Research & Development at Ergoresearch.
This added competitive edge will enable Ergoresearch to conquer new market shares for its 'custom' products like the OdrA, its new world patented distraction-rotation device.
"The OdrA device's delivery of pain relief to knee osteoarthritis sufferers has been proven both scientifically and clinically. The spectacular results observed are however dependent on accurate custom manufacturing. Owing to this new advanced technology, shipping plaster molds to a central-fab custom orthotics facility is no longer necessary. Launching an optical scanner system at such a low entry cost is a major milestone for Ergoresearch. It will lead to new strategic alliances with healthcare professionals around the globe.
"Challenges were many but our strategic alliance with CRIM¹, our partnership with Protéor, France's leader in orthopedics, the Ergoresearch team's enthusiastic participation and the financial support of the NRC² led this project to successful completion," says Sylvain Boucher, President and CEO of Ergoresearch. He also extends his thanks to the project's many stakeholders who made this orthopedic breakthrough possible.
CRIM¹: Computer Research Institute of Montreal
NRC²: National Research Council
Ergoresearch is a Canadian based company that designs and manufactures cutting edge technologies for the orthopedic industry. The Company holds patents in the field of bionics including intellectual property used in the Power Knee, the world's only motor-powered prosthesis for above-knee amputees. Ergoresearch has developed and commercialized Web-Fit™, the first robotized custom-fit orthotics manufacturing software program and launched OdrA, a world -patented orthotic device that revolutionizes the treatment of pain associated with knee osteoarthritis
Ergoresearch owns Quebec's leading network in orthotics, with over 100 corporate and satellite centres under the Clinique du pied Équilibre, Orthoconcept and Laboratoire Langelier banners. The Company is listed on the TSX Venture Exchange (TSXV) under the symbol ERG.
This is not an invitation to purchase securities listed on TSX Venture Exchange. TMX Group and its affiliates do not endorse or recommend any of the referenced securities or investment advisors. Please seek professional advice to evaluate specific securities.
Forward looking statements
Certain statements in this Press Release contain forward-looking statements and information that may entail certain risks related to uncertainties. Such statements are based on management's expectations and no assurance can be given that potential future results or circumstances described in the forward looking statements will be achieved or will occur. Such risks factors include, but are not limited to, those related to the Corporation's ability to finance its activities, competition, ability to negotiate and maintain partnerships, the market acceptance of the said product, fluctuations in operating results, the impact of general economics, industry and market conditions, the ability to recruit and retain qualified employees, the success of research and development programs, fluctuations in cash flow, expectations regarding market demand for particular products, the strength of intellectual property, market dependence on new product development, the trust invested in sub-contractors or their core personnel, as well as other documents containing risks and uncertainties which are put forth every now and then by the firm to various Canadian securities and exchange commissions and made available at www.sedar.com.
The reader should not give great importance to forward-looking statements as the results may differ from conclusions, predictions or projections contained in such forward-looking statements; and certain important factors or hypothesis taken into account in reaching conclusions or the preparation of a projection or prediction may prove to be incorrect in fact.
Management disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or circumstances. All figures are in Canadian dollars, unless otherwise specified.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Image with caption: "WEB- fit software by Ergoresearch - 3D scan of a leg. (CNW Group/Ergoresearch Ltd)". Image available at: http://photos.newswire.ca/images/download/20140416_C4069_PHOTO_EN_39350.jpg
Image with caption: "Nancy Trempe orthotic clinician, 3D scan of a patient, scanning device and software developped by Ergoresearch. (CNW Group/Ergoresearch Ltd)". Image available at: http://photos.newswire.ca/images/download/20140416_C4069_PHOTO_EN_39352.jpg
Image with caption: "Traditional cast-making methods that rely on plaster bandaging. (CNW Group/Ergoresearch Ltd)". Image available at: http://photos.newswire.ca/images/download/20140416_C4069_PHOTO_EN_39348.jpg
SOURCE: Ergoresearch Ltd
For further information:
Sylvain Boucher, President and CEO - Ergoresearch Ltd
Tel.: 450-973-6700, x. 213 | email@example.com
Émilie Vion, Communications Coordinator - Ergoresearch Ltd
Tel.: 450-973-6700, x. 242 | firstname.lastname@example.org